Recent Quarter Total Invested
$4.56 M
Recent Quarter Institutional Ownership Percentage
32.4%
Total Invested of Last Quarter
$21.69 M
Ownership Percentage of Last Quarter
43.61%
Cara Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 08/13/2024 | 2.25 M | $580,586 | -9.31% | 4.12% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 08/15/2024 | 1.94 M | $499,415 | 6.65% | 3.55% |
| CHESCAPMANAGER LLC | 08/14/2024 | 1.70 M | $439,144 | 0.00% | 3.12% |
| FARALLON CAPITAL MANAGEMENT LLC | 08/14/2024 | 1.56 M | $401,513 | 0.00% | 2.85% |
| BNP PARIBAS ARBITRAGE, SNC | 08/13/2024 | 1.08 M | $277,816 | 276.24% | 1.97% |
| RENAISSANCE TECHNOLOGIES LLC | 08/09/2024 | 1.07 M | $274,964 | -20.02% | 1.95% |
| TWO SIGMA ADVISERS, LP | 08/14/2024 | 861,600 | $222,293 | 30.57% | 1.58% |
| BLACKROCK INC. | 08/13/2024 | 744,707 | $192,134 | -78.23% | 1.36% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2024 | 586,755 | $151,383 | -11.34% | 1.07% |
| BANK OF AMERICA CORP /DE/ | 08/14/2024 | 477,683 | $123,242 | -24.92% | 0.88% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 472,686 | $121,984 | -53.73% | 0.87% |
| STIFEL FINANCIAL CORP | 08/13/2024 | 443,151 | $114,333 | -40.23% | 0.81% |
| Y-INTERCEPT (HONG KONG) LTD | 08/14/2024 | 414,731 | $107,001 | 100.00% | 0.76% |
| GOLDMAN SACHS GROUP INC | 08/13/2024 | 389,681 | $100,537 | 654.57% | 0.71% |
| JANE STREET GROUP, LLC | 08/15/2024 | 376,502 | $97,138 | 100.00% | 0.69% |
| NORTHERN TRUST CORP | 08/14/2024 | 369,706 | $95,384 | -5.40% | 0.68% |
| ACADIAN ASSET MANAGEMENT LLC | 08/06/2024 | 267,303 | $68,000 | -20.02% | 0.49% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2024 | 254,169 | $65,576 | -8.57% | 0.47% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/12/2024 | 223,213 | $57,589 | -32.11% | 0.41% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/15/2024 | 185,847 | $47,949 | 200.65% | 0.34% |
| STATE STREET CORP | 08/14/2024 | 180,800 | $46,646 | -81.97% | 0.33% |
| FMR LLC | 08/13/2024 | 177,523 | $45,801 | 9.49% | 0.33% |
| HRT FINANCIAL LP | 08/12/2024 | 163,697 | $42,000 | 100.00% | 0.30% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 08/13/2024 | 159,469 | $41,143 | 100.00% | 0.29% |
| LPL FINANCIAL LLC | 08/07/2024 | 151,195 | $39,008 | 0.29% | 0.28% |
| CENTIVA CAPITAL, LP | 08/14/2024 | 96,800 | $24,974 | 100.00% | 0.18% |
| TUDOR INVESTMENT CORP ET AL | 08/14/2024 | 93,116 | $24,024 | 0.00% | 0.17% |
| VIRTU FINANCIAL LLC | 08/09/2024 | 75,987 | $20,000 | 100.00% | 0.14% |
| JPMORGAN CHASE & CO | 08/12/2024 | 74,857 | $19,313 | 119.91% | 0.14% |
| UBS GROUP AG | 08/14/2024 | 73,037 | $18,844 | 42.01% | 0.13% |
| MORGAN STANLEY | 10/17/2024 | 69,285 | $17,875 | -34.55% | 0.13% |
| PENSERRA CAPITAL MANAGEMENT LLC | 08/13/2024 | 68,078 | $18,000 | 3.88% | 0.12% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 08/14/2024 | 66,610 | $17,186 | 100.00% | 0.12% |
| B. RILEY WEALTH ADVISORS, INC. | 08/19/2024 | 61,608 | $15,895 | 10.71% | 0.11% |
| PINNACLE ASSOCIATES LTD | 07/30/2024 | 57,350 | $14,796 | 100.00% | 0.11% |
| PALOMA PARTNERS MANAGEMENT CO | 08/14/2024 | 55,000 | $14,190 | 100.00% | 0.10% |
| VERITION FUND MANAGEMENT LLC | 08/14/2024 | 50,000 | $12,900 | 0.00% | 0.09% |
| CITADEL ADVISORS LLC | 08/14/2024 | 45,592 | $11,763 | 100.00% | 0.08% |
| GROUP ONE TRADING, L.P. | 08/14/2024 | 34,775 | $8,972 | -13.01% | 0.06% |
| AQR CAPITAL MANAGEMENT LLC | 08/14/2024 | 33,005 | $8,516 | 14.53% | 0.06% |
| RHUMBLINE ADVISERS | 08/01/2024 | 30,677 | $7,912 | -60.12% | 0.06% |
| CITIGROUP INC | 08/12/2024 | 29,520 | $7,616 | -44.34% | 0.05% |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 08/14/2024 | 24,405 | $6,296 | 100.00% | 0.04% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 08/13/2024 | 22,527 | $5,812 | 97.17% | 0.04% |
| RATHBONES GROUP PLC | 08/09/2024 | 20,164 | $5,202 | 0.00% | 0.04% |
| CORSAIR CAPITAL MANAGEMENT, L.P. | 08/13/2024 | 19,864 | $5,125 | 100.00% | 0.04% |
| BARCLAYS PLC | 08/14/2024 | 16,518 | $4,000 | -49.05% | 0.03% |
| ASSENAGON ASSET MANAGEMENT S.A. | 07/18/2024 | 14,353 | $3,703 | -91.72% | 0.03% |
| WEALTH EFFECTS LLC | 08/02/2024 | 13,500 | $3,483 | 100.00% | 0.02% |
| RUSSELL INVESTMENTS GROUP, LTD. | 08/08/2024 | 13,141 | $3,390 | 100.00% | 0.02% |
Cara Therapeutics, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of CARA shares?
During the previous two years, 95 institutional investors and hedge funds held shares of Cara Therapeutics, Inc.. The most heavily invested institutionals were:
Centiva Capital, LP: 0
Y-Intercept (Hong Kong) Ltd: 0
WEALTH EFFECTS LLC: 0
Abich Financial Wealth Management LLC: 0
Paloma Partners Management Co: 0
Baader Bank Aktiengesellschaft: 0
-
What percentage of Cara Therapeutics, Inc. stock is owned by institutional investors?
32.40% of Cara Therapeutics, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at CARA ?
Institutional investors have bought a total of 9.37 M shares in the last 24 months. This purchase volume represents approximately $2.72 M in transactions.